Christopher Juncosa serves as Dalya Partners’ Medical Devices & Diagnostics Director. He has more than 20 years of experience in life sciences product development spanning medical devices, in-vitro molecular diagnostics, small and large molecule discovery and development and combination devices.
Christopher has held leadership positions in numerous life science startups facilitating growth strategy development and execution and has spent his entire career in the entrepreneurial life science space.
Christopher also has extensive experience in developing funding and development strategies leveraging both equity and non-dilutive strategies. He has successfully secured funding through BARDA, DTRA, DoD, DARPA, NIH and other agencies for projects ranging from SEED and SBIR through multi-agency development and procurement awards.
Christopher holds a B.S. in BioBehavioral Health and Minor in Neuroscience from the Pennsylvania State University, and an MBA from the University of Illinois.